Identification of CCNA2 as a Therapeutic Target in Cholangiocarcinoma and Evaluation of Indonesian Jamu-Derived Phytochemicals through Network Pharmacology and Molecular Docking
Cholangiocarcinoma (CCA) remains a highly aggressive malignancy with limited therapeutic options and poor prognosis, particularly in Southeast Asia, including Indonesia. The identification of novel molecular targets is essential to improve treatment strategies. This study aimed to identify key therapeutic targets in CC...